Breast tumours that do not express the estrogen receptor, the progesterone receptor, and are HER2-negative, are referred to as “triple-negative” which accounts for approximately 15%-20% of diagnosed breast cancers [178,187,188]. The gene discussed is ESR1; the disease is breast cancer.